Page last updated: 2024-08-21

thymoquinone and Brain Neoplasms

thymoquinone has been researched along with Brain Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Gao, J; Kang, ZF; Mai, A; Ting, WJ; Tu, JY; Yao, QM; Ye, SW1
Khazaei, M; Pazhouhi, M1
Akbor, MM; Bin Sayeed, MS; Chowdhury, FA; Hossain, MK; Mostofa, AGM1
Galadari, S; Pallichankandy, S; Rahman, A; Subburayan, K; Thayyullathil, F1
Akdur, K; Guler, EM; Hatiboglu, MA; Karatas, E; Khan, I; Kocyigit, A; Nalli, A; Tuzgen, S1
Altinoz, MA; Elmaci, I1

Reviews

2 review(s) available for thymoquinone and Brain Neoplasms

ArticleYear
Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.
    BioMed research international, 2018, Volume: 2018

    Topics: Animals; Antineoplastic Agents, Phytogenic; Benzoquinones; Blood-Brain Barrier; Brain Neoplasms; Glioblastoma; Humans; Nigella sativa

2018
Thymoquinone: An edible redox-active quinone for the pharmacotherapy of neurodegenerative conditions and glial brain tumors. A short review.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 83

    Topics: Animals; Antineoplastic Agents; Benzoquinones; Brain Neoplasms; Glioma; Humans; Neurodegenerative Diseases; Oxidation-Reduction

2016

Other Studies

4 other study(ies) available for thymoquinone and Brain Neoplasms

ArticleYear
Thymoquinone induces apoptosis in temozolomide-resistant glioblastoma cells via the p38 mitogen-activated protein kinase signaling pathway.
    Environmental toxicology, 2023, Volume: 38, Issue:1

    Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Drug Resistance, Neoplasm; Glioblastoma; Guanine; Mice; Mice, Nude; p38 Mitogen-Activated Protein Kinases; Purines; Signal Transduction; Temozolomide

2023
Temozolomide-Mediated Apoptotic Death Is Improved by Thymoquinone in U87MG Cell Line.
    Cancer investigation, 2017, Apr-21, Volume: 35, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoquinones; Brain Neoplasms; Cell Line, Tumor; Comet Assay; Cytochromes c; Dacarbazine; Drug Synergism; Glioblastoma; Glutathione; Humans; In Situ Nick-End Labeling; Membrane Potential, Mitochondrial; Nitric Oxide; Reactive Oxygen Species; Staining and Labeling; Temozolomide

2017
Par-4-dependent p53 up-regulation plays a critical role in thymoquinone-induced cellular senescence in human malignant glioma cells.
    Cancer letters, 2018, 07-10, Volume: 426

    Topics: Apoptosis Regulatory Proteins; Benzoquinones; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cellular Senescence; Gene Expression Regulation, Neoplastic; Glioma; Humans; Nigella sativa; Tumor Suppressor Protein p53; Up-Regulation

2018
Thymoquinone Enhances the Effect of Gamma Knife in B16-F10 Melanoma Through Inhibition of Phosphorylated STAT3.
    World neurosurgery, 2019, Volume: 128

    Topics: Actins; Animals; Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Blotting, Western; Brain Neoplasms; Caspase 3; Cell Line, Tumor; Combined Modality Therapy; DNA Damage; In Vitro Techniques; Janus Kinase 2; Melanoma, Experimental; Mice; Phosphoproteins; Proto-Oncogene Proteins c-bcl-2; Radiosurgery; STAT3 Transcription Factor; Survivin

2019